Allakos inc. (ALLK)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities
Net loss

-93,243

-85,372

-75,285

-64,701

-55,006

-43,538

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,500

1,500

1,100

800

539

200

0

0

0

Stock-based compensation

20,419

15,764

12,438

9,457

6,790

4,570

0

0

0

Net amortization of premiums and discounts on marketable securities

1,641

2,664

2,759

2,551

2,112

1,310

0

0

0

Noncash lease expense

272

275

207

142

73

0

0

0

0

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

970

-463

-1,509

-2,070

-1,604

1,489

0

0

0

Other long-term assets

-

-

-

-

-

-313

0

0

0

Accounts payable

5,385

3,571

892

1,597

1,347

76

0

0

0

Accrued expenses and other current liabilities

727

4,077

5,078

3,516

3,244

2,063

0

0

0

Other long-term liabilities

-276

-70

351

638

911

705

0

0

0

Net cash used in operating activities

-68,321

-63,000

-56,549

-48,701

-42,388

-38,450

0

0

0

Cash flows from investing activities
Purchases of marketable securities

485,994

541,701

336,558

307,839

307,360

236,601

0

0

0

Proceeds from maturities of marketable securities

280,000

230,500

272,500

238,500

173,500

92,500

0

0

0

Purchases of property and equipment

697

770

3,381

5,914

7,050

6,946

0

0

0

Net cash provided by investing activities

-206,691

-311,971

-67,439

-75,253

-140,910

-151,047

0

0

0

Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

138,357

0

0

0

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

0

Proceeds from exercise of stock options

2,113

2,448

0

0

0

-

-

-

-

Proceeds from issuance of common stock under the 2018 ESPP

0

-

-

-

0

-

-

-

-

Payments for deferred financing costs

-

-

-

-

-

-

-

0

0

Net cash provided by financing activities

380,989

381,163

381,159

141,118

140,162

138,752

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

105,951

6,180

257,170

17,162

-43,136

-50,745

0

0

0

Noncash investing and financing items:
Right-of-use assets obtained in exchange for lease obligations

0

6,050

6,050

6,050

6,050

0

0

0

0

Property and equipment purchased in accounts payable

-412

0

-1,402

299

732

313

0

0

0

Deferred initial public offering costs in accounts payable

-

-

-

-

-

-

-

-

0

Vesting of restricted common stock subject to repurchase

14

20

24

24

24

24

0

0

0